A Framework for Future Studies of Personalised Medicine: Affordance, Travelling, and Governance of Expertise
Through individualised genomic knowledge and the digital tools of telemedicine, personalised treatments may be able to solve the “irresolvable” conflict between the evidence-based and person-centred medicine movements. The aim of this chapter is to offer
- PDF / 1,824,060 Bytes
- 136 Pages / 439.37 x 666.142 pts Page_size
- 72 Downloads / 138 Views
For further volumes: http://www.springer.com/series/10293
Kristian Wasen Editor
Emerging Health Technology Relocation of Innovative Visual Knowledge and Expertise
13
Editor Kristian Wasen University of Gothenburg Gothenburg Sweden
ISSN 2193-1704 ISSN 2193-1712 (electronic) ISBN 978-3-642-32569-4 ISBN 978-3-642-32570-0 (eBook) DOI 10.1007/978-3-642-32570-0 Springer Heidelberg New York Dordrecht London
Library of Congress Control Number: 2012949377 © The Author(s) 2013 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Preface
We cannot solve problems by using the same kind of thinking when we created them. Albert Einstein
Professional health care services that we have become accustomed to are essentially products of technological breakthroughs. Advancements in medicine, such as microwave tomography for breast cancer screening, MRI-guided treatment of prostate cancer and biomedical innovations, such as new 3D, 4D and “5D” in vivo imaging technology, are beginning to facilitate the delivery of reliable tests and rapid diagnostic data. There are several emerging technologies on the horizon. For example, a recent EU report about the nano-technology roadmap towards 2020 (Joint European Commission, 2009)1 points to both clinical and economic factors and the b
Data Loading...
